top of page
Endovision is exploring a new frontier in minimally invasive therapy: using a patient's own biologic material to support tissue repair from within the gastrointestinal tract.
From Treatment to Regeneration
Traditional treatment:
1
Remove
2
Repair
3
Manage
Regenerative approach:
1
Harness the Body's Own Biologics
2
Deliver Endoscopically
3
Support Tissue Repair
Current Pilot Study
Autologous PRP Therapy
Endovision is conducting a 15 - subject feasibility and safety pilot study evaluating endoscopic delivery of autologous platelet-rich plasma (PRP) in patients with refractory gastrointestinal fistulas, strictures, and chronic ulcers that have failed conventional medical therapy.
01 - FEASIBILITY
Practical feasibility of endoscopic biologic delivery.
02 - SAFETY
Safety assessment in real-world gastrointestinal conditions.
03 - FOUNDATION
Creating a foundation for expanded investigation of autologous biologics in the GI tract
Why Endoscopy?
✓
Minimally Invasive
✓
Direct access to gastrointestinal tissue
✓
Potential for outpatient treatment
✓
Avoids the need for more invasive access in appropriate circumstances
A Larger Vision
Current
Autologous PRP pilot
→
Next
Expanded investigation
→
Future Possibility
Broader applications
Endovision's existing materials identify chronic diseases such as diabetes and potentially cancer as areas of future possibility. These are future possibilities, not established applications.
bottom of page